1. Molecular Bases of Drug Resistance in Hepatocellular Carcinoma
   Jose J.G. Marin et al, 2020, Cancers CrossRef
2. A novel multi-target RNAi adenovirus inhibits hepatoma cell proliferation, migration, and induction of angiogenesis
   Mei Huang et al, 2016, Oncotarget CrossRef
3. Role of ATP-binding Cassette Transporters in Sorafenib Therapy for Hepatocellular Carcinoma: An Overview
   Maria Manuela Estevinho et al, 2022, Current Drug Targets CrossRef
4. Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems
   Jose J.G. Marin et al, 2022, Seminars in Liver Disease CrossRef
5. A novel SLC25A1 inhibitor, parthenolide, suppresses the growth and stemness of liver cancer stem cells with metabolic vulnerability
   Zhichun Zhang et al, 2023, Cell Death Discovery CrossRef
6. Diagnostic and therapeutic yields of early capsule endoscopy and device-assisted enteroscopy in the setting of overt GI bleeding: a systematic review with meta-analysis
   Maria Manuela Estevinho et al, 2022, Gastrointestinal Endoscopy CrossRef
7. Combination treatment with sorafenib and wh‑4 additively suppresses the proliferation of liver cancer cells
   Su-Hong Chen et al, 2022, Experimental and Therapeutic Medicine CrossRef